16.56
2.47%
-0.42
Handel nachbörslich:
16.56
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Baker Lab’s AI-Driven Antibody Cage Technology Unlocked as Archon Biosciences - Genetic Engineering & Biotechnology News
Short Interest in Assembly Biosciences, Inc. (NASDAQ:ASMB) Declines By 7.9% - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
(ASMB) Investment Analysis and Advice - Stock Traders Daily
Microbiome Manufacturing Market Poised for Robust Growth at 15.4% CAGR by 2031 - WhaTech
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat
(ASMB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - MarketBeat
Assembly Biosciences, Inc.'s (NASDAQ:ASMB) market cap surged US$16m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St
Assembly Biosciences sees major stock purchase by investor Alexander Schornstein By Investing.com - Investing.com Canada
Alexander Schornstein Purchases 10,000 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) Stock - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences CEO sells shares worth $2,917 to cover taxes By Investing.com - Investing.com South Africa
Assembly Biosciences CEO sells shares worth $2,917 to cover taxes - Investing.com India
How To Trade (ASMB) - Stock Traders Daily
Assembly Biosciences executive sells shares worth $2,325 By Investing.com - Investing.com South Africa
Assembly Biosciences executive sells shares worth $2,325 - Investing.com India
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Significant Growth in Short Interest - MarketBeat
Armistice Capital LLC Makes New Investment in Assembly Biosciences, Inc. (NASDAQ:ASMB) - MarketBeat
Investment Analysts’ Updated EPS Estimates for September 24th (AB, AG, AIOT, AIR, AMWL, ASMB, BAG, BDTX, BHVN, BIIB) - Defense World
Assembly Biosciences (NASDAQ:ASMB) Rating Reiterated by HC Wainwright - MarketBeat
(ASMB) Trading Signals - Stock Traders Daily
Assembly Biosciences advances genital herpes treatment study - Investing.com
Assembly Biosciences' Investigational Herpes Treatment Shows Antiviral Efficacy, Safety In Healthy Participants - AOL
Tonight | The Assembly on ABC and ABC iview S1E6 - TV Central
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting - EIN News
The Assembly: Sept 24 - TV Tonight
Jefferies sees upside in Assembly Biosciences stock ahead of key Phase IA data - Investing.com
Schlumberger Limited (NYSE:SLB) Holdings Lifted by Richardson Financial Services Inc. - Defense World
Assembly Biosciences (NASDAQ:ASMB) Upgraded to Buy by Jefferies Financial Group - MarketBeat
Assembly Coffee closing after two years in Ballard - My Ballard
Is Assembly Biosciences (ASMB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Carmel-based MBX Biosciences shares jump 48% in Nasdaq debut - Inside INdiana Business
(ASMB) Technical Data - Stock Traders Daily
Short Interest in Assembly Biosciences, Inc. (NASDAQ:ASMB) Increases By 57.3% - MarketBeat
Microbiome Manufacturing Market Set to Surge with 15.4% CAGR by 2031 - WhaTech
Assembly Biosciences (NASDAQ:ASMB) Share Price Passes Above Two Hundred Day Moving Average of $14.14 - MarketBeat
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Lowered to $160.00 at Barclays - Defense World
Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Significant Drop in Short Interest - MarketBeat
Is Sensus Healthcare (SRTS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Individual investors in Assembly Biosciences, Inc. (NASDAQ:ASMB) are its biggest bettors, and their bets paid off as stock gained 14% last week - Yahoo Finance UK
(ASMB) Investment Analysis - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Stock Price Passes Above 200-Day Moving Average of $13.83 - MarketBeat
MBX Biosciences files intention to go public - Inside INdiana Business
Infectious disease index: Summit, Novavax, Inovio post gains - BioWorld Online
DELFI Diagnostics Appoints Thomas Russo as Chief Financial Officer - citybiz
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):